Abbott Laboratories (ABT) News Today

$104.77
+0.03 (+0.03%)
(As of 04:26 PM ET)
Abbott Laboratories (NYSE:ABT) Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 11.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,053,028 shares of the healthcare product m
Abbott Laboratories (NYSE:ABT) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,226,618 shares of the healthcare product
Principal Securities Inc. Takes $2.93 Million Position in Abbott Laboratories (NYSE:ABT)
Principal Securities Inc. bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,639 shares of the healthcare product maker's stock, val
Breed s Hill Capital LLC Invests $895,000 in Abbott Laboratories (NYSE:ABT)
Breed s Hill Capital LLC bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 8,131 shares of the healthcare product maker's stock,
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Analysts
Abbott Laboratories (NYSE:ABT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommend
Sawgrass Asset Management LLC Acquires 33,316 Shares of Abbott Laboratories (NYSE:ABT)
Sawgrass Asset Management LLC lifted its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 46.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 104,626 shares of the healthcare pro
Abbott Laboratories (NYSE:ABT) EVP Lisa D. Earnhardt Sells 22,852 Shares
Abbott Laboratories (NYSE:ABT - Get Free Report) EVP Lisa D. Earnhardt sold 22,852 shares of the stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $106.25, for a total transaction of $2,428,025.00. Following the sale, the executive vice president now directly owns 61,462 shares in the company, valued at $6,530,337.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Abbott Laboratories Q1 Earnings Transcript
Abbott Laboratories (NYSE:ABT) Shares Acquired by Apollon Wealth Management LLC
Apollon Wealth Management LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 41.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 64,490 shares of the healthcare product maker's stock after
RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) Stock Position Lifted by Private Advisor Group LLC
Private Advisor Group LLC lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 18.0% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 167,778 shares of the healthcare product maker's stock after purchasing a
National Bank of Canada FI Reduces Position in Abbott Laboratories (NYSE:ABT)
National Bank of Canada FI lessened its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,040,659 shares of the healthcare product maker's stoc
Abbott Laboratories (NYSE:ABT) Shares Bought by Nations Financial Group Inc. IA ADV
Nations Financial Group Inc. IA ADV raised its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 22.3% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 39,890 shares of the healthcare product maker's stock after acquiring an additio
Abbott Laboratories (NYSE:ABT) Shares Purchased by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 2.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 291,047 shares of the healthcare product maker's stock after ac
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook (ABT)
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook.
Graham Capital Wealth Management LLC Buys New Shares in Abbott Laboratories (NYSE:ABT)
Graham Capital Wealth Management LLC bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 12,285 shares of the healthcare product maker's stock, va
Raymond James Financial Services Advisors Inc. Acquires 9,365 Shares of Abbott Laboratories (NYSE:ABT)
Raymond James Financial Services Advisors Inc. boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 1.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 827,824 shares of the healt
Waycross Partners LLC Cuts Stake in Abbott Laboratories (NYSE:ABT)
Waycross Partners LLC decreased its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 70.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,289 shares of the healthcare product maker's stock after selling 10,200 shar
Amica Mutual Insurance Co. Buys 15,087 Shares of Abbott Laboratories (NYSE:ABT)
Amica Mutual Insurance Co. boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 14.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 117,532 shares of the healthcare product maker's stoc
Retirement Systems of Alabama Cuts Stock Position in Abbott Laboratories (NYSE:ABT)
Retirement Systems of Alabama trimmed its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,093,549 shares of the healthcare product maker's stock aft
Raymond James & Associates Has $358.47 Million Holdings in Abbott Laboratories (NYSE:ABT)
Raymond James & Associates boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 3.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,153,909 shares of the healthcare pr
Truist Financial Corp Sells 96,735 Shares of Abbott Laboratories (NYSE:ABT)
Truist Financial Corp reduced its position in Abbott Laboratories (NYSE:ABT - Free Report) by 3.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,839,281 shares of the healthcare product maker's stock after selling 96,735 shares during the period.
Abbott Laboratories (NYSE:ABT) Position Reduced by Bank Julius Baer & Co. Ltd Zurich
Bank Julius Baer & Co. Ltd Zurich trimmed its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 43.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,141,237 shares of the healthcare product maker's
Schnieders Capital Management LLC Sells 17,738 Shares of Abbott Laboratories (NYSE:ABT)
Schnieders Capital Management LLC lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 25.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 52,778 shares of the healthcare product maker's stock aft
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Trims Stake in Abbott Laboratories (NYSE:ABT)
Loring Wolcott & Coolidge Fiduciary Advisors LLP MA reduced its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,758,011 shares of th
Abbott Laboratories (NYSE:ABT) PT Lowered to $140.00 at Barclays
Barclays dropped their price objective on shares of Abbott Laboratories from $141.00 to $140.00 and set an "overweight" rating on the stock in a research note on Monday.
Commerzbank Aktiengesellschaft FI Boosts Position in Abbott Laboratories (NYSE:ABT)
Commerzbank Aktiengesellschaft FI increased its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 591.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 225,953 shares of the healthcare product maker's stock after
abrdn plc Boosts Stake in Abbott Laboratories (NYSE:ABT)
abrdn plc lifted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 150.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,220,503 shares of the healthcare product maker
Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

Millionaire investor and Republican donor makes surprising election prediction (Ad)

Find out who Louis believes is going to win the election... And why that will launch a second boom in AI stocks

Click for his six specific AI stock in the crosshairs

ABT Media Mentions By Week

ABT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABT
News Sentiment

0.95

0.58

Average
Medical
News Sentiment

ABT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABT Articles
This Week

19

18

ABT Articles
Average Week

Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:ABT) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners